Όλο το DSpace

Πλοήγηση ανά Θέμα "Raynaud phenomenon"

Αποτελέσματα 1-6 από 6

    • Diabetes mellitus vs. Raynaud disease: Different lung vascular bed disorders 

      Boulbou, M. S.; Gourgoulianis, K. I.; Krommydas, G. C.; Klisiaris, V. K.; Arseniou, A. A.; Dafopoulos, K. C.; Molyvdas, P. A. (2002)
      Background. In type 11 diabetes mellitus there are few data concerning pulmonary function abnormalities. In normal subjects and in patients with primary Raynaud phenomenon, cold pressor test induces a decrease in carbon ...

    • Disease-related autoantibody profile in patients with systemic sclerosis 

      Liaskos C., Marou E., Simopoulou T., Barmakoudi M., Efthymiou G., Scheper T., Meyer W., Bogdanos D.P., Sakkas L.I. (2017)
      Background: Autoantibodies (autoAbs) help in diagnosis and predicting clinical phenotypes in systemic sclerosis (SSc). Aim of the study: To determine the clinical utility of 13 SSc-related autoAbs in SSc patients. Material ...

    • Interstitial lung disease in anti-synthetase syndrome 

      Kourkouni E., Mitsogiannis G., Simopoulou T., Liaskos C., Katsiari C.G., Daniil Z., Gourgoulianis K., Bogdanos D.P., Sakkas L.I. (2019)
      Anti-synthetase syndrome is an autoimmune disorder characterized by the presence of autoantibodies against aminoacyl transfer RNA (tRNA) synthetases, and myositis, interstitial lung disease (ILD), arthritis, fever and ...

    • Primary sjögren’s syndrome and cardiovascular disease 

      Melissaropoulos K., Bogdanos D., Dimitroulas T., Sakkas L.I., Kitas G.D., Daoussis D. (2020)
      Sjögren’s syndrome is a rheumatic autoimmune disease that primarily affects middle-aged women and runs a slowly progressing course with sicca symptoms being the prevalent manifestation. Premature atherosclerosis and increased ...

    • The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis 

      Ntelis K., Solomou E.E., Sakkas L., Liossis S.-N., Daoussis D. (2017)
      Introduction Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, autoimmunity, and widespread dermal and visceral fibrosis. This article summarizes the current knowledge about the potential ...

    • Targeting very early systemic sclerosis: a case-based review 

      Melissaropoulos K., Kraniotis P., Bogdanos D., Dimitroulas T., Sakkas L., Daoussis D. (2019)
      It is unknown whether treatment in very early/early systemic sclerosis (SSc) can affect long-term outcomes. A case-based review was conducted (i) to assess the effect of rituximab (RTX) in very early SSc and (ii) to explore ...